Efficient suppression of murine arthritis by combined anticytokine small interfering RNA lipoplexes

Arthritis and Rheumatism

Volumn 58, Issue 8, 2008, Pages 2356-2367

  Khoury, Maroun ^a   Escriou, Virginie ^b   Courties, Gabriel ^a   Galy, Anne ^c,d   Yao, Roseline ^c   Largeau, Céline ^b   Scherman, Daniel ^b   Jorgensen, Christian ^e   Apparailly, Florence ^e,f  

^a Montpellier University Medical Center   (France)

^b PSL RESEARCH UNIVERSITY   (France)

^c GÉNÉTHON   (France)

^d UNIVERSITÉ PARIS SACLAY   (France)

^e LAPEYRONIE HOSPITAL   (France)

^f HÔPITAL SAINT ELOI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

1,2 DIOLEOYL SN GLYCERO 3 PHOSPHOETHANOLAMINE; 2 [3 (BIS (3 AMINOPROPYL)AMINO)PROPYLAMINO]N DITETRADECYLCARBAMOYLMETHYLACETAMIDE; DNA; INTERLEUKIN 18; INTERLEUKIN 18 SMALL INTERFERING RNA; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA SMALL INTERFERING RNA; INTERLEUKIN 6; INTERLEUKIN 6 SMALL INTERFERING RNA; LIPOPLEX; LIPOPOLYSACCHARIDE; LIPOSOME; MESSENGER RNA; SMALL INTERFERING RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DESTRUCTION; CARTILAGE DEGENERATION; CONTROLLED STUDY; DISEASE SEVERITY; DRUG DISTRIBUTION; INFLAMMATION; JOINT SWELLING; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; RNA INTERFERENCE; TH1 CELL;

EID: 49549101615     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.23660     Document Type: Article

References (40)

1. Illei GG, Lipsky PE. Novel, non-antigen-specific therapeutic approaches to autoimmune/inflammatory diseases. Curr Opin Immunol 2000;12:712-8.
2. Bongartz T, Sutton AJ, Sweeting MJ, Buchan I, Matteson EL, Montori V. Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials. JAMA 2006;295:2275-85.
3. McInnes IB, Schett G. Cytokines in the pathogenesis of rheumatoid arthritis [review]. Nat Rev Immunol 2007;7:429-42.
4. Ghayur T, Banerjee S, Hugunin M, Butler D, Herzog L, Carter A, et al. Caspase-1 processes IFN-γ-inducing factor and regulates LPS-induced IFN-γ production. Nature 1997;386:619-23.
5. Kohno K, Kataoka J, Ohtsuki T, Suemoto Y, Okamoto I, Usui M, et al. IFN-γ-inducing factor (IGIF) is a costimulatory factor on the activation of Th1 but not Th2 cells and exerts its effect independently of IL-12. J Immunol 1997;158:1541-50.
6. Tsutsui H, Nakanishi K, Matsui K, Higashino K, Okamura H, Miyazawa Y, et al. IFN-γ-inducing factor up-regulates Fas ligand-mediated cytotoxic activity of murine natural killer cell clones. J Immunol 1996;157:3967-73.
7. Gracie JA, Forsey RJ, Chan WL, Gilmour A, Leung BP, Greer MR, et al. A proinflammatory role for IL-18 in rheumatoid arthritis. J Clin Invest 1999;104:1393-401.
8. Luft T, Jefford M, Luetjens P, Hochrein H, Masterman KA, Maliszewski C, et al. IL-1β enhances CD40 ligand-mediated cytokine secretion by human dendritic cells (DC): a mechanism for T cell-independent DC activation. J Immunol 2002;168:713-22.
9. Wesa AK, Galy A. IL-1β induces dendritic cells to produce IL-12. Int Immunol 2001;13:1053-61.
10. Dayer JM, Graham R, Russell G, Krane SM. Collagenase production by rheumatoid synovial cells: stimulation by a human lymphocyte factor. Science 1977;195:181-3.
11. Dinarello CA, Cannon JG, Wolff SM, Bernheim HA, Beutler B, Cerami A, et al. Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1. J Exp Med 1986;163:1433-50.
12. Zwerina J, Redlich K, Polzer K, Joosten L, Kronke G, Distler J, et al. TNF-induced structural joint damage is mediated by IL-1. Proc Natl Acad Sci U S A 2007;104:11742-7.
13. Feldmann M, Brennan FM, Maini RN. Role of cytokines in rheumatoid arthritis. Annu Rev Immunol 1996;14:397-440.
14. McInnes IB, Gracie JA. Targeting cytokines beyond tumor necrosis factor-α and interleukin-1 in rheumatoid arthritis. Curr Rheumatol Rep 2004;6:336-42.
15. Taylor PC. Antibody therapy for rheumatoid arthritis. Curr Opin Pharmacol 2003;3:323-8.
16. Caplen NJ. Gene therapy progress and prospects: downregulating gene expression: the impact of RNA interference [review]. Gene Ther 2004;11:1241-8.
17. Mello CC, Conte D Jr. Revealing the world of RNA interference. Nature 2004;431:338-42.
18. Karagiannis TC, El-Osta A. RNA interference and potential therapeutic applications of short interfering RNAs [review]. Cancer Gene Ther 2005;12:787-95.
19. Inoue A, Takahashi KA, Mazda O, Terauchi R, Arai Y, Kishida T, et al. Electro-transfer of small interfering RNA ameliorated arthritis in rats. Biochem Biophys Res Commun 2005;336:903-8.
20. Schiffelers RM, Xu J, Storm G, Woodle MC, Scaria PV. Effects of treatment with small interfering RNA on joint inflammation in mice with collagen-induced arthritis. Arthritis Rheum 2005;52: 1314-8.
21. Khoury M, Louis-Plence P, Escriou V, Noel D, Largeau C, Cantos C, et al. Efficient new cationic liposome formulation for systemic delivery of small interfering RNA silencing tumor necrosis factor α in experimental arthritis. Arthritis Rheum 2006;54:1867-77.
22. Byk G, Dubertret C, Escriou V, Frederic M, Jaslin G, Rangara R, et al. Synthesis, activity, and structure - activity relationship studies of novel cationic lipids for DNA transfer. J Med Chem 1998;41:229-35.
23. Perez N, Plence P, Millet V, Greuet D, Minot C, Noel D, et al. Tetracycline transcriptional silencer tightly controls transgene expression after in vivo intramuscular electrotransfer: application to interleukin 10 therapy in experimental arthritis. Hum Gene Ther 2002;13:2161-72.
24. Djouad F, Fritz V, Apparailly F, Louis-Plence P, Bony C, Sany J, et al. Reversal of the immunosuppressive properties of mesenchymal stem cells by tumor necrosis factor α in collagen-induced arthritis. Arthritis Rheum 2005;52:1595-603.
25. Laderach D, Compagno D, Danos O, Vainchenker W, Galy A. RNA interference shows critical requirement for NF-κB p50 in the production of IL-12 by human dendritic cells. J Immunol 2003; 171:1750-7.
26. Apparailly F, Verwaerde C, Jacquet C, Auriault C, Sany J, Jorgensen C. Adenovirus-mediated transfer of viral IL-10 gene inhibits murine collagen-induced arthritis. J Immunol 1998;160: 5213-20.
27. Butler DM, Malfait AM, Maini RN, Brennan FM, Feldmann M. Anti-IL-12 and anti-TNF antibodies synergistically suppress the progression of murine collagen-induced arthritis. Eur J Immunol 1999;29:2205-12.
28. Kuiper S, Joosten LA, Bendele AM, Edwards CK III, Arntz OJ, Helsen MM, et al. Different roles of tumour necrosis factor α and interleukin 1 in murine streptococcal cell wall arthritis. Cytokine 1998;10:690-702.
29. Dinarello CA, Moldawer LL. Proinflammatory and anti-inflammatory cytokines in rheumatoid arthritis: a primer for clinicians. 3rd ed. Thousand Oaks (CA): Amgen; 2002. p. 352.
30. Van den Berg WB. Arguments for interleukin 1 as a target in chronic arthritis. Ann Rheum Dis 2000;59 Suppl 1:i81-4.
31. H-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat Immunol 2007;8:967-74.
32. Hoeve MA, Savage ND, de Boer T, Langenberg DM, de Waal Malefyt R, Ottenhoff TH, et al. Divergent effects of IL-12 and IL-23 on the production of IL-17 by human T cells. Eur J Immunol 2006;36:661-70.
33. Lewis DL, Wolff JA. Delivery of siRNA and siRNA expression constructs to adult mammals by hydrodynamic intravascular injection. Methods Enzymol 2005;392:336-50.
34. Morrissey DV, Lockridge JA, Shaw L, Blanchard K, Jensen K, Breen W, et al. Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs. Nat Biotechnol 2005;23:1002-7.
35. Song E, Lee SK, Wang J, Ince N, Ouyang N, Min J, et al. RNA interference targeting Fas protects mice from fulminant hepatitis. Nat Med 2003;9:347-51.
36. Khazanov E, Simberg D, Barenholz Y. Lipoplexes prepared from cationic liposomes and mammalian DNA induce CpG-independent, direct cytotoxic effects in cell cultures and in mice. J Gene Med 2006;8:998-1007.
37. Santel A, Aleku M, Keil O, Endruschat J, Esche V, Fisch G, et al. A novel siRNA-lipoplex technology for RNA interference in the mouse vascular endothelium. Gene Ther 2006;13:1222-34.
38. Sorensen DR, Leirdal M, Sioud M. Gene silencing by systemic delivery of synthetic siRNAs in adult mice. J Mol Biol 2003;327: 761-6.
39. Yano J, Hirabayashi K, Nakagawa S, Yamaguchi T, Nogawa M, Kashimori I, et al. Antitumor activity of small interfering RNA/ cationic liposome complex in mouse models of cancer. Clin Cancer Res 2004;10:7721-6.
40. Escriou V, Ciolina C, Lacroix F, Byk G, Scherman D, Wils P. Cationic lipid-mediated gene transfer: effect of serum on cellular uptake and intracellular fate of lipopolyamine/DNA complexes. Biochim Biophys Acta 1998;1368:276-88.